ACADIAN ASSET MANAGEMENT LLC - ONCOGENEX PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$13,000
+44.4%
12,9410.0%0.00%
Q1 2016$9,000
-25.0%
12,941
+32.9%
0.00%
Q4 2015$12,000
+20.0%
9,737
+115.9%
0.00%
Q3 2015$10,000
-23.1%
4,511
-24.8%
0.00%
Q1 2015$13,0005,9980.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
Acrospire Investment Management LLC 5,200$5,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$46,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders